IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
公司网站 :
http://www.imv-inc.com
总经理:Andrew Hall
建立时间:2007
公司总部:Dartmouth
领域:Health technology
行业:Biotechnology